세계의 약용 사료 첨가제 시장 규모, 점유율, 성장 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2024-2032년)

Growth Factors of medicated feed additives Market

The global medicated feed additives market continues to expand steadily as livestock producers and animal nutrition companies prioritize disease prevention, improved feed efficiency, and enhanced animal health management. According to the 2024 industry assessment, the market size was valued at USD 4.01 billion in 2024, reflecting rising dependence on medicated feed to prevent infections and ensure food safety across large-scale poultry, porcine, bovine, and aquaculture operations. The market is projected to grow to USD 4.19 billion in 2025 and reach USD 5.97 billion by 2032, exhibiting a CAGR of 5.2% from 2025 to 2032.

Growing Demand for Quality Animal Protein Fuels Market Expansion

Medicated feed additives play a crucial role in preventing and treating diseases in farmed animals, especially poultry, pigs, fish, and cattle-species highly vulnerable to rapid infection spread in dense production environments. Increasing meat consumption and rising consumer awareness about high-quality protein have amplified the need for veterinary-regulated feed formulations.

In 2024, the U.K. reported 77,000 tonnes of pig meat production, an 8.9% increase from 2023, demonstrating the growing demand for high-output livestock production systems that rely on medicated feed for disease control. This surge, alongside intensified animal health challenges, is pushing major market players such as Cargill, Phibro Animal Health, Kemin Industries, Elanco, and Virbac to expand their product portfolios and manufacturing capacities.

Market Snapshot - 2024 to 2032

Market Size Overview

• 2024: USD 4.01 billion
• 2025: USD 4.19 billion
• 2032: USD 5.97 billion

Leading Region in 2024 - North America

North America accounted for 34.41% of the global market in 2024, corresponding to a regional market size of USD 1.38 billion. The region's growth is driven by:

• A large livestock population
• High consumption of meat and dairy
• Advanced animal health infrastructure
• Strategic product launches and acquisitions

Companies such as Phibro Animal Health and Cargill strengthened regional capabilities through acquisitions, including Cargill's 2024 purchase of two U.S. feed mills to expand its animal nutrition operations.

Key Regional Highlights

United States

The U.S. leads North America due to strong awareness of animal nutritional needs and rising meat production. Strategic investments, such as Cargill's 2024 acquisition, support industry expansion.

China

China exhibits rapid growth in medicated feed adoption, supported by rising aquaculture and livestock production. The Evonik-Vland Biotech joint venture in 2023 strengthened regional supply of gut health solutions.

Europe

Europe held the second-largest market share in 2024, supported by strict regulatory standards and rising poultry consumption. The EU's 2024 investment of USD 389.6 million in animal health and welfare further boosted the region's modernization efforts.

Japan

Japan maintains stringent quality standards in feed manufacturing. Companies like Meiji Holdings ensure high-quality, safety-compliant solutions for the domestic market.

Market Dynamics

Drivers - Rising Protein Consumption

Growing demand for chicken, pork, and dairy-supported by acquisitions such as GrainCorp's 2023 purchase of Performance Feeds-accelerates adoption of medicated feed additives globally.

Restraints - Antibiotic Resistance

Government bans, such as the FSSAI ban on antibiotics in food animals in 2024, are limiting use of antibiotic-based feed additives, pushing the industry toward natural alternatives.

Opportunities - Companion Animal Nutrition

Rising pet ownership is opening new opportunities. Virbac's 2025 launch of Veterinary HPM Digestive Support diets for dogs and cats reflects this emerging segment.

Challenges - Supply Chain Disruptions

Scarcity of raw materials and price fluctuations, especially in active pharmaceutical ingredients, continue to challenge manufacturers.

Competitive Landscape

The industry is moderately consolidated, with global leaders such as ADM, Cargill, Kemin, Phibro Animal Health, Nutreco, CHS Inc., and Alltech holding strong positions through R&D investments, product diversification, and global expansion.

Recent developments include:

• April 2025: FDA approval for Tejo Marine Biotechnology's Faunamor for fish health
• January 2025: Godrej Agrovet's launch of Argo Rid for parasitic control in aquaculture
• March 2025: TechMix upgrading its equine nutrition product line

Segmentation By Type

• Antimicrobials
• Anticoccidials
• Antiparasitics
• Others

By Animal Type

• Companion
  • Feline
  • Canine
  • Avian
  • Others
• Livestock
  • Poultry
  • Porcine
  • Bovine
  • Others

By Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others

By Region

• North America (By Type, By Animal Type, By Distribution Channel, By Country)
  • U.S.
  • Canada
• Europe (By Type, By Animal Type, By Distribution Channel, By Country/ Sub-Region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, By Animal Type, By Distribution Channel, By Country/ Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, By Animal Type, By Distribution Channel, By Country/ Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, By Animal Type, By Distribution Channel, By Country/ Sub-Region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2024
• 4.2. Regulatory Scenario By Key Countries/ Region, 2024
• 4.3. Pet Ownership Statistics, By Key Countries/ Region, 2024
• 4.4. New Type Launches, By Key Players
• 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
• 4.6. Impact of COVID-19 on the Global Medicated Feed Additives Market

5. Global Medicated Feed Additives Market Analysis, Insights and Forecast, 2019-2032

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Antimicrobials
  • 5.1.2. Anti-coccidials
  • 5.1.3. Antiparasitics
  • 5.1.4. Others
• 5.2. Market Analysis, Insights and Forecast - By Animal Type
  • 5.2.1. Companion
    • 5.2.1.1. Feline
    • 5.2.1.2. Canine
    • 5.2.1.3. Avian
    • 5.2.1.4. Others
  • 5.2.2. Livestock
    • 5.2.2.1. Poultry
    • 5.2.2.2. Porcine
    • 5.2.2.3. Bovine
    • 5.2.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
  • 5.3.1. Veterinary Hospitals
  • 5.3.2. Veterinary Clinics
  • 5.3.3. Pharmacies & Drug Stores
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Medicated Feed Additives Market Analysis, Insights and Forecast, 2019-2032

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Antimicrobials
  • 6.1.2. Anti-coccidials
  • 6.1.3. Antiparasitics
  • 6.1.4. Others
• 6.2. Market Analysis, Insights and Forecast - By Animal Type
  • 6.2.1. Companion
    • 6.2.1.1. Feline
    • 6.2.1.2. Canine
    • 6.2.1.3. Avian
    • 6.2.1.4. Others
  • 6.2.2. Livestock
    • 6.2.2.1. Poultry
    • 6.2.2.2. Porcine
    • 6.2.2.3. Bovine
    • 6.2.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
  • 6.3.1. Veterinary Hospitals
  • 6.3.2. Veterinary Clinics
  • 6.3.3. Pharmacies & Drug Stores
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Medicated Feed Additives Market Analysis, Insights and Forecast, 2019-2032

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Antimicrobials
  • 7.1.2. Anti-coccidials
  • 7.1.3. Antiparasitics
  • 7.1.4. Others
• 7.2. Market Analysis, Insights and Forecast - By Animal Type
  • 7.2.1. Companion
    • 7.2.1.1. Feline
    • 7.2.1.2. Canine
    • 7.2.1.3. Avian
    • 7.2.1.4. Others
  • 7.2.2. Livestock
    • 7.2.2.1. Poultry
    • 7.2.2.2. Porcine
    • 7.2.2.3. Bovine
    • 7.2.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
  • 7.3.1. Veterinary Hospitals
  • 7.3.2. Veterinary Clinics
  • 7.3.3. Pharmacies & Drug Stores
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.4.1. Germany
  • 7.4.2. U.K.
  • 7.4.3. France
  • 7.4.4. Italy
  • 7.4.5. Spain
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Medicated Feed Additives Market Analysis, Insights and Forecast, 2019-2032

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Antimicrobials
  • 8.1.2. Anti-coccidials
  • 8.1.3. Antiparasitics
  • 8.1.4. Others
• 8.2. Market Analysis, Insights and Forecast - By Animal Type
  • 8.2.1. Companion
    • 8.2.1.1. Feline
    • 8.2.1.2. Canine
    • 8.2.1.3. Avian
    • 8.2.1.4. Others
  • 8.2.2. Livestock
    • 8.2.2.1. Poultry
    • 8.2.2.2. Porcine
    • 8.2.2.3. Bovine
    • 8.2.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
  • 8.3.1. Veterinary Hospitals
  • 8.3.2. Veterinary Clinics
  • 8.3.3. Pharmacies & Drug Stores
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Medicated Feed Additives Market Analysis, Insights and Forecast, 2019-2032

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Antimicrobials
  • 9.1.2. Anti-coccidials
  • 9.1.3. Antiparasitics
  • 9.1.4. Others
• 9.2. Market Analysis, Insights and Forecast - By Animal Type
  • 9.2.1. Companion
    • 9.2.1.1. Feline
    • 9.2.1.2. Canine
    • 9.2.1.3. Avian
    • 9.2.1.4. Others
  • 9.2.2. Livestock
    • 9.2.2.1. Poultry
    • 9.2.2.2. Porcine
    • 9.2.2.3. Bovine
    • 9.2.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
  • 9.3.1. Veterinary Hospitals
  • 9.3.2. Veterinary Clinics
  • 9.3.3. Pharmacies & Drug Stores
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Medicated Feed Additives Market Analysis, Insights and Forecast, 2019-2032

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Antimicrobials
  • 10.1.2. Anti-coccidials
  • 10.1.3. Antiparasitics
  • 10.1.4. Others
• 10.2. Market Analysis, Insights and Forecast - By Animal Type
  • 10.2.1. Companion
    • 10.2.1.1. Feline
    • 10.2.1.2. Canine
    • 10.2.1.3. Avian
    • 10.2.1.4. Others
  • 10.2.2. Livestock
    • 10.2.2.1. Poultry
    • 10.2.2.2. Porcine
    • 10.2.2.3. Bovine
    • 10.2.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
  • 10.3.1. Veterinary Hospitals
  • 10.3.2. Veterinary Clinics
  • 10.3.3. Pharmacies & Drug Stores
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2024)
• 11.2. Company Profiles
  • 11.2.1. Archer Daniels Midland Company (ADM)
    • 11.2.1.1. Overview
    • 11.2.1.2. Types
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Cargill, Incorporated
    • 11.2.2.1. Overview
    • 11.2.2.2. Types
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Meiji Holdings Co., Ltd.
    • 11.2.3.1. Overview
    • 11.2.3.2. Types
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Godrej Agrovet Limited
    • 11.2.4.1. Overview
    • 11.2.4.2. Types
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Novozymes A/S
    • 11.2.5.1. Overview
    • 11.2.5.2. Types
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Nutreco
    • 11.2.6.1. Overview
    • 11.2.6.2. Types
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. CHS Inc.
    • 11.2.7.1. Overview
    • 11.2.7.2. Types
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Phibro Animal Health Corporation
    • 11.2.8.1. Overview
    • 11.2.8.2. Types
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Kemin Industries
    • 11.2.9.1. Overview
    • 11.2.9.2. Types
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Alltech Inc
    • 11.2.10.1. Overview
    • 11.2.10.2. Types
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)